Retinitis Pigmentosa

Penulis

  • Richardo Rusli Falkutas Kedokteran UKRIDA, Jakarta, Indonesia

DOI:

https://doi.org/10.55175/cdk.v47i5.378

Kata Kunci:

Bone spicule, degenerasi retina herediter, retinitis pigmentosa

Abstrak

Retinitis pigmentosa merupakan sekelompok penyakit degenerasi retina herediter yang ditandai oleh disfungsi progresif fotoreseptor disertai hilangnya sel secara progresif dan akhirnya menyebabkan atrofi beberapa lapisan retina. Beberapa kasus retinitis pigmentosa merupakan penyakit genetik yang diturunkan, dikarenakan kelainan pada informasi genetik. Pada funduskopi, dapat ditemukan perubahan pigmen retina seperti bone spicules. ERG menunjukkan dominasi penurunan amplitudo gelombang-b dalam kondisi skotopik. Farmakoterapi seperti vitamin A, docosahexaenoic acid (DHA), dan lutein/zeaxanthin bertujuan untuk mengurangi morbiditas dan mencegah komplikasi.

 

Retinitis pigmentosa is a group of hereditary retinal degeneration characterized by progressive photoreceptor dysfunction and is accompanied by progressive cell loss and eventually causes atrophy in several layers of the retina. Almost all types of retinitis pigmentosa are inherited, caused by errors in genetic information. In funduscopy, changes in retinal pigment can be found in the form of bone spicules. ERG shows a decrease in the b-wave amplitude that dominates in scotopic conditions. Pharmacotherapy such as vitamin A, docosahexaenoic acid (DHA), and lutein/zeaxanthin, aims to reduce morbidity and prevent complications.

Unduhan

Data unduhan belum tersedia.

Referensi

Ilyas S. Ilmu penyakit mata. Fakultas Kedokteran Universitas Indonesia. Jakarta; 2004

The Royal College of Ophthalmologists and Royal National Institute of Blind People. Understanding retinitis pigmentosa. 2014.

Hamel C. Retinitis pigmentosa. Orphanet J Rare Diseases. 2006;1:40

Guyton, Arthur C. Textbook of medical physiology. Philadelphia: Elsevier; 2006.p. 626-36.

Ilyas S. Retinitis pigmentosa. Ilmu penyakit mata. 3rd Ed. Jakarta: Balai Penerbit Fakultas Kedokteran Universitas Indonesia; 2008. p. 225-6.

American Academy of Ophthalmology. Basic and clinical science course. Ch. 12. Retina and vitreous. San Fransisco: AAO. 2016 – 2017

Octavia SA, Himayani R. Diagnosa dan tatalaksana retinitis pigmentosa: Studi kasus. Majority 2017;6(3):75-80

German LO, Insua MF, Gentili C. Docosahexaenoic acid prevents apoptosis of retina photoreceptors by activating the ERK/MAPK pathway. J Neurochemistry 2006;98(5):1507-20

Bersin EL, Rosner B, Sandberg MA. Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment. Arch Ophthalmol. 2004;122:1297–305

Jia YP, Sun L, Yu HS. The pharmacological effects of lutein and zeaxanthin on visual disorders and cognition diseases. Molecules. 2017;22:610

Bahrami H, Melia M, Dagnelie G. Lutein supplementation in retinitis pigmentosa: Based vision assessment in a randomized double-masked placebo-controlled clinical trial. BMC Ophthalmol 2006;.6:23

Diterbitkan

2020-07-01

Cara Mengutip

Rusli, R. (2020). Retinitis Pigmentosa. Cermin Dunia Kedokteran, 47(5), 351–353. https://doi.org/10.55175/cdk.v47i5.378

Terbitan

Bagian

Articles